In this week’s Bio Bulletin, we feature: BioUtah Spring Member Mixer—Register Today! Halia Therapeutics Reports Positive Final Phase 2 Ofirnoflast Data 2026 White Hat Life Sciences Investor Conference FDA Commissioner Marty Makary Resigns Portal Pours: Salt Lake City Halia Appoints Han Myint, MD, FACP as CMO ARUP Laboratories Launches National Infectious Disease Test Positivity Trends […]

FDA stated that the “proposed data may be capable of supporting the submission and review of an [NDA] under the accelerated approval pathway” for CNM-Au8 based on neurofilament light (NfL) biomarker data

VOXZOGO is the only approved treatment for children with achondroplasia starting at birth, with over 10 years of clinical research demonstrating the long-term benefit on complications associated with achondroplasia

Two ARUP Medical Directors Receive Career Achievement Awards

As gaps in early detection persist, a 45-second voice analysis offers a new way to identify signals of stress, anxiety, and depression during Mental Health Awareness Month

What to Know About the Reauthorized SBIR/STTR Grant Programs

H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity

Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026